FDA Warning Letter — OraWell USA
The FDA took a Warning Letter action against OraWell USA on September 21, 2011 (Philadelphia, PA). The action was issued by CBER and concerns biologics products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- OraWell USA
- Date
- September 21, 2011
- Fiscal Year
- 2011
- Product Type
- Biologics
- Center
- CBER
- Location
- Philadelphia, PA (United States)